Ecabet Sodium

依卡倍特钠

Report date: 2022/07/14 17:50:11
NME

Base Information

Drug NameEcabet Sodium
Drug Alias Name依卡倍特ecabetumecabetGastromTA-2711 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin agonists
TargetsProstaglandin
Therapy Area/IndicationsDry Eye SyndromesStomach UlcerGastritis
Global Approved IndicationsStomach UlcerGastritis
Approved Indications in ChinaStomach UlcerGastritis
Original Approved Country/TerritoryJapan
Original Approved Date1993/12/15
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesISTA Pharmaceuticals IncMitsubishi Tanabe PharmaGrand Pharma (Tianjin) Co Ltd
Inactive CompaniesBausch & Lomb Incorporated
Active IndicationsStomach UlcerGastritis
Inactive IndicationsDry Eye Syndromes

Other Information

ATC CodeA02B
Related LinksDrugBankKEGG